$LFCR
LIFECORE BIOMEDICAL, INC. \DE\ Stock $lfcr

$lfcr Overview Financials Valuation SEC Filings Company Website

2020 Q4 Form 10-Q Financial Statement

#000100528621000009 Filed on January 07, 2021

Income Statement

Concept	2020 Q4	2019 Q4
Revenue	$130.9M	$142.6M
YoY Change	-8.2%	14.48%
Cost Of Revenue	$110.3M	$127.1M
YoY Change	-13.23%	18.02%
Gross Profit	$20.64M	$15.51M
YoY Change	33.02%	-8.12%
Gross Profit Margin	15.76%	10.88%
Selling, General & Admin	$16.11M	$18.73M
YoY Change	-14.0%	30.06%
% of Gross Profit	78.04%	120.72%
Research & Development	$2.572M	$2.822M
YoY Change	-8.86%	14.02%
% of Gross Profit	12.46%	18.19%
Depreciation & Amortization	$4.730M	$4.530M
YoY Change	4.42%	36.73%
% of Gross Profit	22.92%	29.2%
Operating Expenses	$22.10M	$21.55M
YoY Change	2.57%	27.7%
Operating Profit	-$1.466M	-$6.036M
YoY Change	-75.71%	-60460.0%
Interest Expense	$3.039M	$2.169M
YoY Change	40.11%	-823.0%
% of Operating Profit
Other Income/Expense, Net	-$11.79M	-$6.000K
YoY Change	196350.0%	-101.0%
Pretax Income	-$16.00M	-$7.905M
YoY Change	102.42%	-2658.25%
Income Tax	-$2.700M	-$1.165M
% Of Pretax Income
Net Earnings	-$13.30M	-$6.740M
YoY Change	97.34%	1054.11%
Net Earnings / Revenue	-10.16%	-4.73%
Basic Earnings Per Share	-$0.45	-$0.23
Diluted Earnings Per Share	-$0.45	-$0.23
COMMON SHARES
Basic Shares Outstanding	29.28M shares	29.16M shares
Diluted Shares Outstanding	29.28M shares	29.16M shares

Balance Sheet

Concept	2020 Q4	2019 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$2.500M	$1.600M
YoY Change	56.25%	6.67%
Cash & Equivalents	$2.491M	$1.594M
Short-Term Investments
Other Short-Term Assets	$13.90M	$10.10M
YoY Change	37.62%	71.19%
Inventory	$71.20M	$58.56M
Prepaid Expenses
Receivables	$66.55M	$69.96M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$154.2M	$140.2M
YoY Change	9.99%	51.6%
LONG-TERM ASSETS
Property, Plant & Equipment	$171.0M	$204.7M
YoY Change	-16.47%	20.04%
Goodwill	$69.39M	$77.25M
YoY Change	-10.18%	41.71%
Intangibles	$4.200M	$29.93M
YoY Change	-85.97%	86.72%
Long-Term Investments	$45.10M	$61.30M
YoY Change	-26.43%	-9.99%
Other Assets	$1.332M	$2.583M
YoY Change	-48.43%	-44.98%
Total Long-Term Assets	$345.0M	$419.8M
YoY Change	-17.83%	31.53%
TOTAL ASSETS
Total Short-Term Assets	$154.2M	$140.2M
Total Long-Term Assets	$345.0M	$419.8M
Total Assets	$499.2M	$560.0M
YoY Change	-10.86%	36.04%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$60.89M	$47.15M
YoY Change	29.16%	48.63%
Accrued Expenses	$24.20M	$23.30M
YoY Change	3.86%	39.52%
Deferred Revenue	$644.0K	$611.0K
YoY Change	5.4%	-64.41%
Short-Term Debt	$77.00M	$61.50M
YoY Change	25.2%	46.43%
Long-Term Debt Due	$11.19M	$11.72M
YoY Change	-4.56%	137.31%
Total Short-Term Liabilities	$173.9M	$144.4M
YoY Change	20.47%	48.64%
LONG-TERM LIABILITIES
Long-Term Debt	$82.00M	$107.5M
YoY Change	-23.7%	208.03%
Other Long-Term Liabilities	$5.357M	$28.50M
YoY Change	-81.2%	493.75%
Total Long-Term Liabilities	$87.36M	$107.5M
YoY Change	-18.71%	208.03%
TOTAL LIABILITIES
Total Short-Term Liabilities	$173.9M	$144.4M
Total Long-Term Liabilities	$87.36M	$107.5M
Total Liabilities	$290.2M	$300.9M
YoY Change	-3.56%	90.36%
SHAREHOLDERS EQUITY
Retained Earnings	$46.94M	$97.91M
YoY Change	-52.05%	-10.09%
Common Stock	$29.00K	$29.00K
YoY Change	0.0%	3.57%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$208.9M	$259.1M
YoY Change
Total Liabilities & Shareholders Equity	$499.2M	$560.0M
YoY Change	-10.86%	36.04%

Cashflow Statement

Concept	2020 Q4	2019 Q4
OPERATING ACTIVITIES
Net Income	-$13.30M	-$6.740M
YoY Change	97.34%	1054.11%
Depreciation, Depletion And Amortization	$4.730M	$4.530M
YoY Change	4.42%	36.73%
Cash From Operating Activities	$1.440M	-$9.480M
YoY Change	-115.19%	-463.22%
INVESTING ACTIVITIES
Capital Expenditures	-$2.790M	-$6.050M
YoY Change	-53.88%	45.78%
Acquisitions
YoY Change
Other Investing Activities	$8.030M	$70.00K
YoY Change	11371.43%	-65.0%
Cash From Investing Activities	$5.250M	-$5.970M
YoY Change	-187.94%	51.14%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-4.980M	15.05M
YoY Change	-133.09%	910.07%
NET CHANGE
Cash From Operating Activities	1.440M	-9.480M
Cash From Investing Activities	5.250M	-5.970M
Cash From Financing Activities	-4.980M	15.05M
Net Change In Cash	1.710M	-400.0K
YoY Change	-527.5%	-366.67%
FREE CASH FLOW
Cash From Operating Activities	$1.440M	-$9.480M
Capital Expenditures	-$2.790M	-$6.050M
Free Cash Flow	$4.230M	-$3.430M
YoY Change	-223.32%	-150.74%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0001005286
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--05-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Amendment Flag AmendmentFlag	false
CY2019Q4	us-gaap	Revenue From Contract With Customer Product And Service Extensible List RevenueFromContractWithCustomerProductAndServiceExtensibleList	us-gaap:ProductMember
CY2020Q4	us-gaap	Revenue From Contract With Customer Product And Service Extensible List RevenueFromContractWithCustomerProductAndServiceExtensibleList	us-gaap:ProductMember
	us-gaap	Revenue From Contract With Customer Product And Service Extensible List RevenueFromContractWithCustomerProductAndServiceExtensibleList	us-gaap:ProductMember
	us-gaap	Revenue From Contract With Customer Product And Service Extensible List RevenueFromContractWithCustomerProductAndServiceExtensibleList	us-gaap:ProductMember
	us-gaap	Type Of Cost Good Or Service Extensible List TypeOfCostGoodOrServiceExtensibleList	us-gaap:ProductMember
CY2020Q4	us-gaap	Type Of Cost Good Or Service Extensible List TypeOfCostGoodOrServiceExtensibleList	us-gaap:ProductMember
CY2019Q4	us-gaap	Type Of Cost Good Or Service Extensible List TypeOfCostGoodOrServiceExtensibleList	us-gaap:ProductMember
	us-gaap	Type Of Cost Good Or Service Extensible List TypeOfCostGoodOrServiceExtensibleList	us-gaap:ProductMember
CY2019Q3	us-gaap	Accounting Standards Update Extensible List AccountingStandardsUpdateExtensibleList	us-gaap:AccountingStandardsUpdate201602Member
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2020-11-29
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	0-27446
	dei	Entity Registrant Name EntityRegistrantName	LANDEC CORPORATION
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	94-3025618
	dei	Entity Address Address Line1 EntityAddressAddressLine1	2811 Airpark Drive
	dei	Entity Address City Or Town EntityAddressCityOrTown	Santa Maria,
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	93455
	dei	City Area Code CityAreaCode	650
	dei	Local Phone Number LocalPhoneNumber	306-1650
	dei	Security12b Title Security12bTitle	Common stock, par value $0.001 per share
	dei	Trading Symbol TradingSymbol	LNDC
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Entity Shell Company EntityShellCompany	false
CY2021Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	29323153	shares
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2491000	USD
CY2020Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	360000	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	66545000	USD
CY2020Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	76206000	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	71202000	USD
CY2020Q2	us-gaap	Inventory Net InventoryNet	66311000	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	13949000	USD
CY2020Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	14230000	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	154187000	USD
CY2020Q2	us-gaap	Assets Current AssetsCurrent	157107000	USD
CY2020Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	45100000	USD
CY2020Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	56900000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	170973000	USD
CY2020Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	192338000	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	21070000	USD
CY2020Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	25321000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	69386000	USD
CY2020Q2	us-gaap	Goodwill Goodwill	69386000	USD
CY2020Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	25328000	USD
CY2020Q2	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	25328000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	11784000	USD
CY2020Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	12777000	USD
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1332000	USD
CY2020Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2156000	USD
CY2020Q4	us-gaap	Assets Assets	499160000	USD
CY2020Q2	us-gaap	Assets Assets	541313000	USD
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	60892000	USD
CY2020Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	51647000	USD
CY2020Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	7689000	USD
CY2020Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	9034000	USD
CY2020Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	12715000	USD
CY2020Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	9978000	USD
CY2020Q4	lndc	Operating And Finance Lease Liability Current OperatingAndFinanceLeaseLiabilityCurrent	3785000	USD
CY2020Q2	lndc	Operating And Finance Lease Liability Current OperatingAndFinanceLeaseLiabilityCurrent	4423000	USD
CY2020Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	644000	USD
CY2020Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	352000	USD
CY2020Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	77000000	USD
CY2020Q2	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	77400000	USD
CY2020Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	11189000	USD
CY2020Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	11554000	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	173914000	USD
CY2020Q2	us-gaap	Liabilities Current LiabilitiesCurrent	164388000	USD
CY2020Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	82000000	USD
CY2020Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	101363000	USD
CY2020Q4	lndc	Operating And Finance Lease Liability Noncurrent OperatingAndFinanceLeaseLiabilityNoncurrent	22206000	USD
CY2020Q2	lndc	Operating And Finance Lease Liability Noncurrent OperatingAndFinanceLeaseLiabilityNoncurrent	26378000	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	6745000	USD
CY2020Q2	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	13588000	USD
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	5357000	USD
CY2020Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	4552000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	290222000	USD
CY2020Q2	us-gaap	Liabilities Liabilities	310269000	USD
CY2020Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000000	shares
CY2020Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000000	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	29323000	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	29323000	shares
CY2020Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	29224000	shares
CY2020Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	29224000	shares
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	29000	USD
CY2020Q2	us-gaap	Common Stock Value CommonStockValue	29000	USD
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	164068000	USD
CY2020Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	162578000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	46944000	USD
CY2020Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	71245000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-2103000	USD
CY2020Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-2808000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	208938000	USD
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	231044000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	499160000	USD
CY2020Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	541313000	USD
CY2020Q4	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	130904000	USD
CY2019Q4	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	142593000	USD
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	266547000	USD
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	281307000	USD
CY2020Q4	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	110267000	USD
CY2019Q4	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	127079000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	229564000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	250457000	USD
CY2020Q4	us-gaap	Gross Profit GrossProfit	20637000	USD
CY2019Q4	us-gaap	Gross Profit GrossProfit	15514000	USD
	us-gaap	Gross Profit GrossProfit	36983000	USD
	us-gaap	Gross Profit GrossProfit	30850000	USD
CY2020Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2572000	USD
CY2019Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2822000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5080000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5643000	USD
CY2020Q4	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	16106000	USD
CY2019Q4	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	18728000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	34009000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	35623000	USD
CY2020Q4	us-gaap	Legal Fees LegalFees	1763000	USD
	us-gaap	Investment Income Dividend InvestmentIncomeDividend	563000	USD
CY2020Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-2700000	USD
CY2019Q4	us-gaap	Legal Fees LegalFees	0	USD
	us-gaap	Legal Fees LegalFees	1763000	USD
	us-gaap	Legal Fees LegalFees	0	USD
CY2020Q4	us-gaap	Restructuring Costs RestructuringCosts	1662000	USD
CY2019Q4	us-gaap	Restructuring Costs RestructuringCosts	0	USD
	us-gaap	Restructuring Costs RestructuringCosts	10066000	USD
	us-gaap	Restructuring Costs RestructuringCosts	0	USD
CY2020Q4	us-gaap	Operating Expenses OperatingExpenses	22103000	USD
CY2019Q4	us-gaap	Operating Expenses OperatingExpenses	21550000	USD
	us-gaap	Operating Expenses OperatingExpenses	50918000	USD
	us-gaap	Operating Expenses OperatingExpenses	41266000	USD
CY2020Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-1466000	USD
CY2019Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-6036000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-13935000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-10416000	USD
CY2020Q4	us-gaap	Investment Income Dividend InvestmentIncomeDividend	281000	USD
CY2019Q4	us-gaap	Investment Income Dividend InvestmentIncomeDividend	281000	USD
	us-gaap	Investment Income Dividend InvestmentIncomeDividend	562000	USD
CY2020Q4	us-gaap	Investment Income Interest InvestmentIncomeInterest	10000	USD
CY2019Q4	us-gaap	Investment Income Interest InvestmentIncomeInterest	25000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	18000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	50000	USD
CY2020Q4	us-gaap	Interest Expense InterestExpense	3039000	USD
CY2019Q4	us-gaap	Interest Expense InterestExpense	2169000	USD
	us-gaap	Interest Expense InterestExpense	6148000	USD
	us-gaap	Interest Expense InterestExpense	4244000	USD
CY2020Q4	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-11787000	USD
CY2019Q4	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-6000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-11808000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-6000	USD
CY2020Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-16001000	USD
CY2019Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-7905000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-31310000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-14054000	USD
CY2019Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1165000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-7009000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-2530000	USD
CY2020Q4	us-gaap	Net Income Loss NetIncomeLoss	-13301000	USD
CY2019Q4	us-gaap	Net Income Loss NetIncomeLoss	-6740000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-24301000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-11524000	USD
CY2020Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.45
CY2019Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.23
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.83
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.40
CY2020Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.45
CY2019Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.23
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.83
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.40
CY2020Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	29280000	shares
CY2019Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	29155000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	29261000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	29147000	shares
CY2020Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	29280000	shares
CY2019Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	29155000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	29261000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	29147000	shares
CY2020Q4	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax	121000	USD
CY2019Q4	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax	39000	USD
	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax	228000	USD
	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax	-226000	USD
CY2020Q4	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	401000	USD
CY2019Q4	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	127000	USD
	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	705000	USD
	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	-485000	USD
CY2020Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	401000	USD
CY2019Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	127000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	705000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-485000	USD
CY2020Q4	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-12900000	USD
CY2019Q4	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-6613000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-23596000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-12009000	USD
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	231044000	USD
CY2020Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	0	USD
CY2020Q3	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	82000	USD
CY2020Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	892000	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	-11000000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	304000	USD
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	221158000	USD
CY2020Q4	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	0	USD
CY2020Q4	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	215000	USD
CY2020Q4	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	895000	USD
CY2020Q4	us-gaap	Net Income Loss NetIncomeLoss	-13301000	USD
CY2020Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	401000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	208938000	USD
CY2019Q2	us-gaap	Stockholders Equity StockholdersEquity	270144000	USD
CY2019Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	0	USD
CY2019Q3	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	55000	USD
CY2019Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	528000	USD
CY2019Q3	us-gaap	Net Income Loss NetIncomeLoss	-4784000	USD
CY2019Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-612000	USD
CY2019Q3	us-gaap	Stockholders Equity StockholdersEquity	264947000	USD
CY2019Q4	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	30000	USD
CY2019Q4	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	75000	USD
CY2019Q4	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	787000	USD
CY2019Q4	us-gaap	Net Income Loss NetIncomeLoss	-6740000	USD
CY2019Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	127000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	259076000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-24301000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-11524000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	9826000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	9030000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	1787000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	1315000	USD
	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-7070000	USD
	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-2624000	USD
	us-gaap	Fair Value Assets Measured On Recurring Basis Change In Unrealized Gain Loss FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	-11800000	USD
	us-gaap	Fair Value Assets Measured On Recurring Basis Change In Unrealized Gain Loss FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	200000	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	34000	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	15000	USD
	us-gaap	Restructuring Settlement And Impairment Provisions RestructuringSettlementAndImpairmentProvisions	6005000	USD
	us-gaap	Restructuring Settlement And Impairment Provisions RestructuringSettlementAndImpairmentProvisions	406000	USD
	us-gaap	Other Noncash Expense OtherNoncashExpense	21000	USD
	us-gaap	Other Noncash Expense OtherNoncashExpense	206000	USD
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	USD
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-500000	USD
	lndc	Accounts Receivable Allowance For Credit Loss Reserve AccountsReceivableAllowanceForCreditLossReserve	0	USD
	lndc	Accounts Receivable Allowance For Credit Loss Reserve AccountsReceivableAllowanceForCreditLossReserve	1202000	USD
	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-9661000	USD
	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	397000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	4891000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	4431000	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-1539000	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	554000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	10539000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-6105000	USD
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-1345000	USD
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-1988000	USD
	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	4627000	USD
	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	1145000	USD
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	292000	USD
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	112000	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	29000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	18456000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-14922000	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	12885000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	7407000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	16029000	USD
	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	0	USD
	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	364000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	5478000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-15636000	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	297000	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	130000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	20062000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	5062000	USD
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	24000000	USD
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	62900000	USD
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	24400000	USD
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	53400000	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	1237000	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	766000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	30000	USD
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	USD
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	27500000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-21996000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	31072000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1938000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	514000	USD
CY2020Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	553000	USD
CY2019Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1465000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2491000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1979000	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1526000	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	3174000	USD
	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make certain estimates and judgments that affect the amounts reported in the financial statements and accompanying notes. The accounting estimates that require management’s most significant and subjective judgments include revenue recognition; loss contingencies; allowance for sales returns and credit losses; self-insurance liabilities; recognition and measurement of current and deferred income tax assets and liabilities; the assessment of recoverability of long-lived asset (including intangible assets), and inventory; the valuation of investments; and the valuation and recognition of stock-based compensation.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These estimates involve the consideration of complex factors and require management to make judgments. The analysis of historical and future trends can require extended periods of time to resolve and are subject to change from period to period. The actual results may differ from management’s estimates.</span></div>
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2491000	USD
CY2020Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	360000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1594000	USD
CY2019Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1080000	USD
CY2020Q4	us-gaap	Restricted Cash RestrictedCash	0	USD
CY2020Q2	us-gaap	Restricted Cash RestrictedCash	193000	USD
CY2019Q4	us-gaap	Restricted Cash RestrictedCash	385000	USD
CY2019Q2	us-gaap	Restricted Cash RestrictedCash	385000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2491000	USD
CY2020Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	553000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1979000	USD
CY2019Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1465000	USD
CY2020Q4	us-gaap	Restricted Cash RestrictedCash	0.0	USD
CY2020Q2	us-gaap	Restricted Cash RestrictedCash	200000	USD
CY2020Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	36325000	USD
CY2020Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	35177000	USD
CY2020Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	26983000	USD
CY2020Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	25856000	USD
CY2020Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	7894000	USD
CY2020Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	5278000	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	71202000	USD
CY2020Q2	us-gaap	Inventory Net InventoryNet	66311000	USD
CY2020Q4	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	0.0	USD
CY2020Q2	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	600000	USD
CY2020Q2	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	438000	USD
	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	102000	USD
	us-gaap	Financing Receivable Allowance For Credit Loss Writeoff After Recovery FinancingReceivableAllowanceForCreditLossWriteoffAfterRecovery	263000	USD
CY2020Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	277000	USD
CY2020Q4	us-gaap	Deferred Finance Costs Current Net DeferredFinanceCostsCurrentNet	800000	USD
CY2020Q4	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	0.0	USD
CY2020Q2	us-gaap	Deferred Finance Costs Current Net DeferredFinanceCostsCurrentNet	400000	USD
	us-gaap	Cash Flow Hedge Gain Loss To Be Reclassified Within Twelve Months CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths	-1700000	USD
CY2019Q1	lndc	Number Of Recalled Products NumberOfRecalledProducts	5	product
CY2019Q4	us-gaap	Gain On Business Interruption Insurance Recovery GainOnBusinessInterruptionInsuranceRecovery	600000	USD
	us-gaap	Gain On Business Interruption Insurance Recovery GainOnBusinessInterruptionInsuranceRecovery	3000000.0	USD
	lndc	Number Of Business Interruption Insurance Recovery Claims NumberOfBusinessInterruptionInsuranceRecoveryClaims	0	insuranceRecoveryClaims
CY2020Q4	us-gaap	Assets Held For Sale Long Lived Fair Value Disclosure AssetsHeldForSaleLongLivedFairValueDisclosure	0.0	USD
CY2020Q2	us-gaap	Assets Held For Sale Long Lived Fair Value Disclosure AssetsHeldForSaleLongLivedFairValueDisclosure	2600000	USD
CY2020Q4	lndc	Impact Of10 Increase In Revenue Growth Sales Increase Decrease To Investment ImpactOf10IncreaseInRevenueGrowthSalesIncreaseDecreaseToInvestment	6000000	USD
CY2020Q4	lndc	Unsuccessful Attempts To Unionize UnsuccessfulAttemptsToUnionize	3	attemptsToUnionize
CY2020Q4	us-gaap	Loss Contingency Estimate Of Possible Loss LossContingencyEstimateOfPossibleLoss	1800000	USD
CY2020Q4	lndc	Impact Of10 Increase In Expense Growth Sales Increase Decrease To Investment ImpactOf10IncreaseInExpenseGrowthSalesIncreaseDecreaseToInvestment	-3200000	USD
CY2020Q4	lndc	Impact Of10 Increase In Income Tax Rates Increase Decrease To Investment ImpactOf10IncreaseInIncomeTaxRatesIncreaseDecreaseToInvestment	-100000	USD
CY2020Q4	lndc	Impact Of10 Increase In Discount Rates Increase Decrease To Investment ImpactOf10IncreaseInDiscountRatesIncreaseDecreaseToInvestment	-1300000	USD
CY2020Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	8900000	USD
CY2020Q2	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	9000000.0	USD
CY2020Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	300000	USD
CY2020Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	0.0	USD
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	21000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	573000	shares
CY2020Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	4100000	shares
CY2020Q4	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	895000	USD
CY2019Q4	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	787000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1787000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1315000	USD
CY2020Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	4700000	USD
CY2010Q3	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	10000000.0	USD
CY2020Q4	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	3800000	USD
	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	0	shares
	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	29147000	shares
CY2020Q4	us-gaap	Net Income Loss NetIncomeLoss	-13301000	USD
CY2019Q4	us-gaap	Net Income Loss NetIncomeLoss	-6740000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-24301000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-11524000	USD
CY2020Q4	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	29280000	shares
CY2019Q4	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	29155000	shares
	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	29261000	shares
CY2020Q4	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2019Q4	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2020Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	29280000	shares
CY2019Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	29155000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	29261000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	29147000	shares
CY2020Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.45
CY2019Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.23
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.83
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.40
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-7000000.0	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-2500000	USD
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.22
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.18
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	900000	USD
CY2020Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	800000	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	800000	USD
CY2020Q2	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	700000	USD
CY2020Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	94000000	USD
CY2020Q2	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	114000000	USD
CY2020Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	811000	USD
CY2020Q2	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	1083000	USD
CY2020Q4	us-gaap	Long Term Debt LongTermDebt	93189000	USD
CY2020Q2	us-gaap	Long Term Debt LongTermDebt	112917000	USD
CY2020Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	11189000	USD
CY2020Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	11554000	USD
CY2020Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	82000000	USD
CY2020Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	101363000	USD
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	3	segment
CY2020Q4	lndc	Number Of Natural Food Brands NumberOfNaturalFoodBrands	4	brand
CY2020Q4	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	130904000	USD
CY2020Q4	us-gaap	Gross Profit GrossProfit	20637000	USD
CY2020Q4	us-gaap	Net Income Loss NetIncomeLoss	-13301000	USD
CY2020Q4	us-gaap	Cost Of Goods And Services Sold Depreciation And Amortization CostOfGoodsAndServicesSoldDepreciationAndAmortization	4291000	USD
CY2020Q4	us-gaap	Investment Income Dividend InvestmentIncomeDividend	281000	USD
CY2020Q4	us-gaap	Investment Income Interest InvestmentIncomeInterest	10000	USD
CY2020Q4	us-gaap	Interest Expense InterestExpense	3039000	USD
CY2020Q4	us-gaap	Restructuring And Related Cost Expected Cost1 RestructuringAndRelatedCostExpectedCost1	29000000.0	USD
CY2020Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-2700000	USD
CY2020Q4	lndc	Corporate Overhead Expense Benefit CorporateOverheadExpenseBenefit	0	USD
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	266547000	USD
	us-gaap	Gross Profit GrossProfit	36983000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-24301000	USD
	us-gaap	Cost Of Goods And Services Sold Depreciation And Amortization CostOfGoodsAndServicesSoldDepreciationAndAmortization	9039000	USD
	us-gaap	Investment Income Dividend InvestmentIncomeDividend	563000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	18000	USD
	us-gaap	Interest Expense InterestExpense	6148000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-7009000	USD
	lndc	Corporate Overhead Expense Benefit CorporateOverheadExpenseBenefit	0	USD
CY2019Q4	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	142593000	USD
CY2019Q4	us-gaap	Gross Profit GrossProfit	15514000	USD
CY2019Q4	us-gaap	Net Income Loss NetIncomeLoss	-6740000	USD
CY2019Q4	us-gaap	Cost Of Goods And Services Sold Depreciation And Amortization CostOfGoodsAndServicesSoldDepreciationAndAmortization	4414000	USD
CY2019Q4	us-gaap	Investment Income Dividend InvestmentIncomeDividend	281000	USD
	us-gaap	Restructuring Costs RestructuringCosts	27351000	USD
CY2019Q4	us-gaap	Investment Income Interest InvestmentIncomeInterest	25000	USD
CY2019Q4	us-gaap	Interest Expense InterestExpense	2169000	USD
CY2019Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1165000	USD
CY2019Q4	lndc	Corporate Overhead Expense Benefit CorporateOverheadExpenseBenefit	0	USD
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	281307000	USD
	us-gaap	Gross Profit GrossProfit	30850000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-11524000	USD
	us-gaap	Cost Of Goods And Services Sold Depreciation And Amortization CostOfGoodsAndServicesSoldDepreciationAndAmortization	8827000	USD
	us-gaap	Investment Income Dividend InvestmentIncomeDividend	562000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	50000	USD
	us-gaap	Interest Expense InterestExpense	4244000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-2530000	USD
	lndc	Corporate Overhead Expense Benefit CorporateOverheadExpenseBenefit	0	USD
CY2020Q4	us-gaap	Restructuring Costs RestructuringCosts	1662000	USD
	us-gaap	Restructuring Costs RestructuringCosts	10066000	USD

Files In Submission

Name	View Source	Status
0001005286-21-000009-index-headers.html	Edgar Link	pending
0001005286-21-000009-index.html	Edgar Link	pending
0001005286-21-000009.txt	Edgar Link	pending
0001005286-21-000009-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
lndc-20201129.htm	Edgar Link	pending
lndc-20201129.xsd	Edgar Link	pending
lndc-20201129xexx311.htm	Edgar Link	pending
lndc-20201129xexx312.htm	Edgar Link	pending
lndc-20201129xexx321.htm	Edgar Link	pending
lndc-20201129xexx322.htm	Edgar Link	pending
lndc-20201129_cal.xml	Edgar Link	unprocessable
lndc-20201129_def.xml	Edgar Link	unprocessable
lndc-20201129_htm.xml	Edgar Link	completed
lndc-20201129_lab.xml	Edgar Link	unprocessable
lndc-20201129_pre.xml	Edgar Link	unprocessable
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$LFCR
LIFECORE BIOMEDICAL, INC. \DE\ Stock $lfcr

2020 Q4 Form 10-Q Financial Statement

#000100528621000009 Filed on January 07, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LFCR LIFECORE BIOMEDICAL, INC. \DE\ Stock $lfcr

2020 Q4 Form 10-Q Financial Statement

#000100528621000009 Filed on January 07, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LFCR
LIFECORE BIOMEDICAL, INC. \DE\ Stock $lfcr